PomDoctor completes U.S. listing ahead of looming Nasdaq crackdown
The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 million Key…
Obesity drug maker Sciwind targets IPO, with heavyweight backers
Supported by Tencent and Meituan, the biotech aims to launch a targeted GLP-1 drug next year that could challenge established products, but it faces stiff competition Key Takeaways: • Clinical…
A wild ride for TransThera investors: what’s the story?
The firm’s core drug has passed a minor clinical milestone, but the rally really took off when the stock was included in an array of indices tracked by passive funds…
WORK Medical enters strategic partnerships in bid to explore RWA initiatives
The medical products maker hopes to leverage RWA technology to transform and leverage its current product infrastructure and budding AI business Key Takeaways: WORK Medical has formed a new alliance…
Fresh from its first profit, Medcaptain steps into IPO spotlight
The maker of medical devices crossed the profit threshold this year thanks to rising demand for its tools to diagnose digestive or urinary problems Key Takeaways: Medcaptain sells its life-support…
Fosun’s Portuguese makeover moves ahead with $360 million health disposal
The conglomerate’s sale of 40% of Luz Saúde is its latest divestment in Portugal, though it continues to own major stakes of that and other assets in the country Key…
Years of losses, thin profit margins leave 160 Health feeling down
After two earlier failures, the online healthcare platform’s IPO has been approved by the Hong Kong Stock Exchange Key Takeaways: 160 Health has been approved to list in Hong Kong,…
